Literature DB >> 12707071

Vascular dementia in a population-based autopsy study.

David S Knopman1, Joseph E Parisi, Bradley F Boeve, Ruth H Cha, Hulya Apaydin, Alessandro Salviati, Steven D Edland, Walter A Rocca.   

Abstract

BACKGROUND: The validity of the clinical diagnosis of vascular dementia (VaD) remains suboptimal.
OBJECTIVE: To investigate clinicopathologic correlations in VaD.
METHODS: We used the medical records-linkage system of the Rochester Epidemiology Project to identify incident cases of dementia in Rochester, Minn, from January 1, 1985, through December 31, 1989. Dementia and Alzheimer disease (AD) were defined by the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Vascular dementia was defined by criteria including imaging results. Pathological characteristics of AD were quantified by means of standard scoring methods for neurofibrillary tangles and neuritic plaques. Vascular pathological findings were assessed by expert neuropathological opinion.
RESULTS: Of 419 patients with dementia who died before the study, neuropathological examination results were available in 89 (21%) with median age at onset of 80 years (range, 50-96 years; 52 [58%] women). Pathological diagnoses were AD in 45 patients (51%), pure VaD in 12 (13%), combined AD and VaD in 11 (12%), and other diagnoses in the remaining 21 patients. Criteria for VaD that required either a temporal relationship between a stroke and dementia onset or worsening, or bilateral infarctions in specified locations demonstrated on imaging results (Mayo Clinic criteria) had 75% sensitivity and 81% specificity for pure VaD (positive likelihood ratio, 3.9; 95% confidence interval, 2.2-6.7). Five cases of pure VaD lacked the temporal relationship and accounted for the imperfect sensitivity of the criteria.
CONCLUSIONS: In this population-based autopsy study, the presence of vascular pathological characteristics in the absence of major AD pathological findings was common. Pure VaD without overt clinical strokes remains a challenge for antemortem diagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 12707071     DOI: 10.1001/archneur.60.4.569

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  60 in total

Review 1.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

2.  Diagnosis, risk factors, and treatment of vascular dementia.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

3.  Longitudinal volumetric MRI change and rate of cognitive decline.

Authors:  D Mungas; D Harvey; B R Reed; W J Jagust; C DeCarli; L Beckett; W J Mack; J H Kramer; M W Weiner; N Schuff; H C Chui
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 4.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 5.  Neuropathology in the adult changes in thought study: a review.

Authors:  Joshua A Sonnen; Eric B Larson; Sebastien Haneuse; Randy Woltjer; Ge Li; Paul K Crane; Suzanne Craft; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

6.  Update on the Diagnosis and Management of Sleep Disturbances in Dementia.

Authors:  Bradley F Boeve
Journal:  Sleep Med Clin       Date:  2008-09

Review 7.  A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.

Authors:  Jacob S Buckley; Shelley R Salpeter
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

Review 8.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

9.  Contribution of vascular pathology to the clinical expression of dementia.

Authors:  Dorothea Strozyk; Dennis W Dickson; Richard B Lipton; Mindy Katz; Carol A Derby; Sunhee Lee; Cuiling Wang; Joe Verghese
Journal:  Neurobiol Aging       Date:  2008-11-08       Impact factor: 4.673

Review 10.  Vascular Cognitive Impairment.

Authors:  Jonathan Graff-Radford
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.